Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions

Our Partners

Q2 Solutions has built relationships with a network of partners to help drive success for our clinical laboratory services

We have built relationships with a network of partners to help drive success in our services. The following are part of our extensive network.

ArcherArcherDX is advancing molecular pathology with a robust technology platform for genetic mutation detection by next-generation sequencing. By combining proprietary Anchored Multiplexed PCR (AMP™) chemistry in an easy-to-use, lyophilized format and powerful bioinformatics software, the Archer® platform dramatically enhances genetic mutation identification and discovery. ArcherDX provides oncology-focused research products and is pursuing regulatory approval for multiple companion diagnostic assays. archerdx.com

HTG is focused on next-generation sequencing (NGS)-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. HTG’s mission is to empower precision medicine at the local level. www.htgmolecular.com

Hµrel Corporation is a world-leading provider of patented, primary hepatocyte-based microlivers and microfluidic cell-based assay platforms. Hµrel’s products are distinctive for their high, stable, and long-enduring levels of metabolic and general cellular competency. Utilizing its patent-pending method of packaging its microlivers for “warm” intercontinental air shipment, Hµrel delivers its products to pharmaceutical and biotech researchers worldwide. Hµrel also offers in vitro safety- and DMPK-directed contract research services based on its microliver products. www.hurelcorp.com

Illumina is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Illumina’s products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. www.illumina.com

Meso Scale Discovery (MSD®) provides high performance, multiplex-enabled biomarker assays for cytokines, toxicology, neurodegeneration and metabolic disease research. MSD’s assays are used by leading biopharmaceutical and academic researchers in human and animal model studies. Its proprietary electrochemiluminescence (ECL) platform delivers exceptional sensitivity, wide dynamic range and rapid turnaround.  www.mesoscale.com

NanoString is a life sciences company focused on cancer research and diagnostics. Proven in over 1,000 peer-reviewed publications, the nCounter® System can combine with 3D biology™ technology to create novel biomarkers. The Prosigna® Breast Cancer Prognostic Gene Signature Assay provides FDA 510(k)-cleared diagnostics with the nCounter Dx Analysis System. www.nanostring.com




©2014 Meso Scale Diagnostics, LLC. All rights reserved